Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
Hot Topics in Blood-based Cancer Screening: Key Information on Multi-Cancer Early Detection from 2023 Spring Oncology Meetings
Hot Topics in Blood-based Cancer Screening: Key Information on Multi-Cancer Early Detection from 2023 Spring Oncology Meetings
Improving Symptoms in Patients with HFrEF Using Novel Device Therapy
Improving Symptoms in Patients with HFrEF Using Novel Device Therapy
Understanding the Fine Print: The Who, When, And What To Do About ARIA in Patients with Alzheimer’s Disease – Primary Care Module
Understanding the Fine Print: The Who, When, And What To Do About ARIA in Patients with Alzheimer’s Disease – Primary Care Module
Directed Relief in CKD-aP: Linking Targeted Therapy to Clinical Outcomes
Directed Relief in CKD-aP: Linking Targeted Therapy to Clinical Outcomes
ASCO 2023 Updates on Targeting HER3 in Breast and Lung Cancers
ASCO 2023 Updates on Targeting HER3 in Breast and Lung Cancers
Essential Aspects of the New ERS/ESC Guidelines on PH Treatment: An Overview
Essential Aspects of the New ERS/ESC Guidelines on PH Treatment: An Overview
Hot Topics from the New ERS/ESC Guidelines: Definitions and Risk Assessment
Hot Topics from the New ERS/ESC Guidelines: Definitions and Risk Assessment
Implications of Aggressive in ‘PAH with comorbidities’ Therapy: What Does That Mean?
Implications of Aggressive in ‘PAH with comorbidities’ Therapy: What Does That Mean?
2022 ERS/ESC PAH Guidelines on Echocardiography
2022 ERS/ESC PAH Guidelines on Echocardiography
How Should Cardiopulmonary Comorbidities Influence PH Treatment Strategy?
How Should Cardiopulmonary Comorbidities Influence PH Treatment Strategy?
Essential Aspects of the New ERS/ESC Treatment Guidelines: Patients With Comorbidities
Essential Aspects of the New ERS/ESC Treatment Guidelines: Patients With Comorbidities
Implications of Aggressive Therapy in ‘PAH Without Comorbidities’
Implications of Aggressive Therapy in ‘PAH Without Comorbidities’